Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine
Clinical trial NCT04164758 · TERMINATED
Trial details
- NCT number
- NCT04164758
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-23
- Primary completion
- 2020-09-25
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.